Simply sign up to the US companies myFT Digest -- delivered directly to your inbox. Strava plans to launch an initial public offering in the US as the leading exercise-tracking app seeks to raise ...

MONROE COUNTY, Ga. — Google has finalized the purchase of 948 acres along Rumble Road near Interstate 75 in Monroe County, paying $42.5 million for land that could house a future data center. The tech ...

Communities often celebrate data center openings. But for all the benefits state and local officials tout for the massive facilities, they also bring their share of problems — including gobbling up ...

On Tuesday, Federal Reserve Bank of Chicago President Austan Goolsbee warned about rising inflation and said it isn't clear whether tariff-induced price hikes will be a one-off or could pose a more ...

Reform UK would win a total of 15 seats in Greater Manchester if a general election were held today, according to a new ‘mega poll’ of UK voters. Seat-by-seat analysis by YouGov, based on a survey of ...

The firm acquired a 2.04-acre plot from Prasoon Spaces for ₹294 crore and a 1.75-acre plot from Chawla Brothers for ₹181 crore Mumbai: Lumina Cloudinfra, a data centre company in Navi Mumbai, recently ...

A bombshell investigation by Hunterbrook Media and journalist Pablo Torre has raised alarms across the sports world, alleging that China may have stolen brainwave data from elite athletes, including ...

After months of mounting pressure from President Donald Trump, the Federal Reserve on Wednesday cut its benchmark interest rate by 25 basis points to 4.00%-4.25% ...

Lawmakers expressed concerns over weather modification and geoengineering. A congressional subcommittee spent nearly two hours on Tuesday discussing the rarely practiced but frequently talked about ...

Texas based offgrid power developer off-gridoff-grid FO Permian Partners has outlined plans to provide more than 5GW of off-grid natural gas power to data centers in the Permian Basin, West Texas. The ...

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.